Clinical Trials Browser

Phase EARLY_PHASE1 × Breast Neoplasms, Male × Neoadjuvant Therapy × Clear all

NCT03387553 2026-05-07

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Breast Neoplasms, Male